Krsnaa Diagnostics [KRSNAA] vs Qualitek Labs [QLL] Detailed Stock Comparison

Krsnaa Diagnostics
NSE
Loading...

Qualitek Labs
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Krsnaa Diagnostics wins in 9 metrics, Qualitek Labs wins in 7 metrics, with 0 ties. Krsnaa Diagnostics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Krsnaa Diagnostics | Qualitek Labs | Better |
---|---|---|---|
P/E Ratio (TTM) | 36.30 | 42.74 | Krsnaa Diagnostics |
Price-to-Book Ratio | 3.13 | 3.10 | Qualitek Labs |
Debt-to-Equity Ratio | 23.06 | 37.74 | Krsnaa Diagnostics |
PEG Ratio | 21.23 | N/A | N/A |
EV/EBITDA | 15.13 | 20.89 | Krsnaa Diagnostics |
Profit Margin (TTM) | 10.82% | 8.97% | Krsnaa Diagnostics |
Operating Margin (TTM) | 16.68% | 20.77% | Qualitek Labs |
EBITDA Margin (TTM) | 16.68% | 20.77% | Qualitek Labs |
Return on Equity | 9.17% | 12.27% | Qualitek Labs |
Return on Assets (TTM) | 5.19% | 7.19% | Qualitek Labs |
Free Cash Flow (TTM) | $-393.00M | $38.67M | Qualitek Labs |
Dividend Yield | 0.36% | N/A | N/A |
1-Year Return | 31.73% | 12.82% | Krsnaa Diagnostics |
Price-to-Sales Ratio (TTM) | 3.87 | 4.30 | Krsnaa Diagnostics |
Enterprise Value | $28.77B | $2.80B | Krsnaa Diagnostics |
EV/Revenue Ratio | 4.01 | 3.98 | Qualitek Labs |
Gross Profit Margin (TTM) | 68.32% | N/A | N/A |
Revenue per Share (TTM) | $222 | $79 | Krsnaa Diagnostics |
Earnings per Share (Diluted) | $23.59 | $7.08 | Krsnaa Diagnostics |
Beta (Stock Volatility) | -0.15 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Krsnaa Diagnostics vs Qualitek Labs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Krsnaa Diagnostics | -0.74% | -4.85% | -1.95% | 8.68% | -3.30% | -11.73% |
Qualitek Labs | -3.07% | 6.68% | 4.51% | 8.38% | 23.88% | -12.54% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Krsnaa Diagnostics | 31.73% | 87.37% | -6.46% | -6.46% | -6.46% | -6.46% |
Qualitek Labs | 12.82% | 104.33% | 104.33% | 104.33% | 104.33% | 104.33% |
Performance & Financial Health Analysis: Krsnaa Diagnostics vs Qualitek Labs
Metric | KRSNAA | QLL |
---|---|---|
Market Information | ||
Market Cap | ₹27.78B | ₹3.02B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 61,282 | 4,120 |
90 Day Avg. Volume | 114,360 | 7,053 |
Last Close | ₹798.05 | ₹311.00 |
52 Week Range | ₹625.75 - ₹1,044.00 | ₹215.05 - ₹375.00 |
% from 52W High | -23.56% | -17.07% |
All-Time High | ₹1,099.70 (Aug 16, 2021) | ₹375.00 (Dec 23, 2024) |
% from All-Time High | -27.43% | -17.07% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.12% | N/A |
Quarterly Earnings Growth | 0.10% | N/A |
Financial Health | ||
Profit Margin (TTM) | 0.11% | 0.09% |
Operating Margin (TTM) | 0.17% | 0.21% |
Return on Equity (TTM) | 0.09% | 0.12% |
Debt to Equity (MRQ) | 23.06 | 37.74 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹273.22 | ₹97.54 |
Cash per Share (MRQ) | ₹21.18 | ₹1.99 |
Operating Cash Flow (TTM) | ₹873.27M | ₹53.16M |
Levered Free Cash Flow (TTM) | ₹210.21M | ₹76.84M |
Dividends | ||
Last 12-Month Dividend Yield | 0.36% | N/A |
Last 12-Month Dividend | ₹2.50 | N/A |
Valuation & Enterprise Metrics Analysis: Krsnaa Diagnostics vs Qualitek Labs
Metric | KRSNAA | QLL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 36.30 | 42.74 |
Forward P/E | 21.23 | N/A |
PEG Ratio | 21.23 | N/A |
Price to Sales (TTM) | 3.87 | 4.30 |
Price to Book (MRQ) | 3.13 | 3.10 |
Market Capitalization | ||
Market Capitalization | ₹27.78B | ₹3.02B |
Enterprise Value | ₹28.77B | ₹2.80B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.01 | 3.98 |
Enterprise to EBITDA | 15.13 | 20.89 |
Risk & Other Metrics | ||
Beta | -0.15 | N/A |
Book Value per Share (MRQ) | ₹273.22 | ₹97.54 |
Financial Statements Comparison: Krsnaa Diagnostics vs Qualitek Labs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | KRSNAA | QLL |
---|---|---|
Revenue/Sales | ₹1.86B | N/A |
Cost of Goods Sold | ₹589.52M | N/A |
Gross Profit | ₹1.27B | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹310.28M | N/A |
EBITDA | ₹573.71M | N/A |
Pre-Tax Income | ₹286.03M | N/A |
Income Tax | ₹79.27M | N/A |
Net Income (Profit) | ₹206.76M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | KRSNAA | QLL |
---|---|---|
Cash & Equivalents | ₹38.45M | ₹51.74M |
Total Current Assets | ₹4.14B | ₹426.08M |
Total Current Liabilities | ₹3.05B | ₹325.84M |
Long-Term Debt | ₹471.56M | ₹308.61M |
Total Shareholders Equity | ₹8.83B | ₹927.82M |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹6.67B | ₹589.98M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | KRSNAA | QLL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | KRSNAA | QLL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 61,282 | 4,120 |
Average Daily Volume (90 Day) | 114,360 | 7,053 |
Shares Outstanding | 32.29M | 9.98M |
Float Shares | 17.39M | 711,777 |
% Held by Insiders | 0.44% | 0.69% |
% Held by Institutions | 0.15% | 0.00% |
Dividend Analysis & Yield Comparison: Krsnaa Diagnostics vs Qualitek Labs
Metric | KRSNAA | QLL |
---|---|---|
Last 12-Month Dividend | ₹2.50 | N/A |
Last 12-Month Dividend Yield | 0.36% | N/A |
3-Year Avg Annual Dividend | ₹2.58 | N/A |
3-Year Avg Dividend Yield | 0.40% | N/A |
3-Year Total Dividends | ₹7.75 | N/A |
Ex-Dividend Date | Sep 13, 2024 | N/A |